TRAMADOL HYDROCHLORIDE AND ACETAMINOPHEN tablet United States - English - NLM (National Library of Medicine)

tramadol hydrochloride and acetaminophen tablet

physicians total care, inc. - tramadol hydrochloride (unii: 9n7r477wck) (tramadol - unii:39j1lgj30j), acetaminophen (unii: 362o9itl9d) (acetaminophen - unii:362o9itl9d) - tramadol hydrochloride 37.5 mg - tramadol hydrochloride and acetaminophen tablets, 37.5 mg/325 mg, are indicated for the short-term (five days or less) management of acute pain. tramadol hydrochloride and acetaminophen tablets should not be administered to patients who have previously demonstrated hypersensitivity to tramadol, acetaminophen, any other component of this product or opioids. tramadol hydrochloride and acetaminophen tablets are contraindicated in any situation where opioids are contraindicated, including acute intoxication with any of the following: alcohol, hypnotics, narcotics, centrally acting analgesics, opioids or psychotropic drugs. tramadol hydrochloride and acetaminophen tablets may worsen central nervous system and respiratory depression in these patients. tramadol may induce psychic and physical dependence of the morphine-type (µ-opioid). (see warnings. ) dependence and abuse, including drug-seeking behavior and taking illicit actions to obtain the drug are not limited to those patients with a prior history

TRAMADOL HYDROCHLORIDE AND ACETAMINOPHEN tablet United States - English - NLM (National Library of Medicine)

tramadol hydrochloride and acetaminophen tablet

keltman pharmaceuticals inc. - tramadol hydrochloride (unii: 9n7r477wck) (tramadol - unii:39j1lgj30j), acetaminophen (unii: 362o9itl9d) (acetaminophen - unii:362o9itl9d) - tramadol hydrochloride 37.5 mg - tramadol hydrochloride and acetaminophen tablets, 37.5 mg/325 mg, are indicated for the short-term (five days or less) management of acute pain. tramadol hydrochloride and acetaminophen tablets should not be administered to patients who have previously demonstrated hypersensitivity to tramadol, acetaminophen, any other component of this product or opioids. tramadol hydrochloride and acetaminophen tablets are contraindicated in any situation where opioids are contraindicated, including acute intoxication with any of the following: alcohol, hypnotics, narcotics, centrally acting analgesics, opioids or psychotropic drugs. tramadol hydrochloride and acetaminophen tablets may worsen central nervous system and respiratory depression in these patients. tramadol may induce psychic and physical dependence of the morphine-type (µ-opioid). (see warnings. ) dependence and abuse, including drug-seeking behavior and taking illicit actions to obtain the drug are not limited to those patients with a prior history of opioid

TRAMADOL HYDROCHLORIDE tablet United States - English - NLM (National Library of Medicine)

tramadol hydrochloride tablet

st. mary's medical park pharmacy - tramadol hydrochloride (unii: 9n7r477wck) (tramadol - unii:39j1lgj30j) - tramadol hydrochloride 50 mg - tramadol hydrochloride tablets, usp are indicated for the management of moderate to moderately severe pain in adults. tramadol hydrochloride tablets should not be administered to patients who have previously demonstrated hypersensitivity to tramadol, any other component of this product or opioids. tramadol hydrochloride is contraindicated in any situation where opioids are contraindicated, including acute intoxication with any of the following: alcohol, hypnotics, narcotics, centrally acting analgesics, opioids or psychotropic drugs. tramadol may worsen central nervous system and respiratory depression in these patients. tramadol hydrochloride is a schedule iv controlled substance. tramadol has mu-opioid agonist activity. tramadol hydrochloride tablet can be abused and may be subject to criminal diversion. addiction is a primary, chronic, neurobiologic disease, with genetic, psychosocial, and environmental factors influencing its development and manifestations. drug addiction is characterized by behaviors that include one or more of the following: impaired control over drug use, compulsive use, use for non-medical purposes, and continued use despite harm or risk of harm, and craving. drug addiction is a treatable disease, utilizing a multidisciplinary approach, but relapse is common. "drug-seeking" behavior is very common in addicts and drug abusers. drug-seeking tactics include emergency calls or visits near the end of office hours, refusal to undergo appropriate examination, testing or referral, repeated "loss" of prescriptions, tampering with prescriptions and reluctance to provide prior medical records or contact information for other treating physician(s). "doctor shopping" to obtain additional prescriptions is common among drug abusers and people suffering from untreated addiction. abuse and addiction are separate and distinct from physical dependence and tolerance. physicians should be aware that addiction may not be accompanied by concurrent tolerance and symptoms of physical dependence in all addicts. in addition, abuse of tramadol hydrochloride tablet can occur in the absence of true addiction and is characterized by misuse for non-medical purposes, often in combination with other psychoactive substances. concerns about abuse and addiction should not prevent the proper management of pain. however all patients treated with opioids require careful monitoring for signs of abuse and addiction, because use of opioid analgesic products carries the risk of addiction even under appropriate medical use. proper assessment of the patient and periodic re-evaluation of therapy are appropriate measures that help to limit the potential abuse of this product. tramadol hydrochloride tablet is intended for oral use only. tolerance is the need for increasing doses of drugs to maintain a defined effect such as analgesia (in the absence of disease progression or other external factors). physical dependence is manifested by withdrawal symptoms after abrupt discontinuation of a drug or upon administration of an antagonist (see also warnings, withdrawal). the opioid abstinence or withdrawal syndrome is characterized by some or all of the following: restlessness, lacrimation, rhinorrhea, yawning, perspiration, chills, myalgia, and mydriasis. other symptoms also may develop, including irritability, anxiety, backache, joint pain, weakness, abdominal cramps, insomnia, nausea, anorexia, vomiting, diarrhea, or increased blood pressure, respiratory rate, or heart rate. generally, tolerance and/or withdrawal are more likely to occur the longer a patient is on continuous therapy with tramadol hydrochloride tablet.

TRAMADOL HYDROCHLORIDE tablet, film coated United States - English - NLM (National Library of Medicine)

tramadol hydrochloride tablet, film coated

ncs healthcare of ky, inc dba vangard labs - tramadol hydrochloride (unii: 9n7r477wck) (tramadol - unii:39j1lgj30j) - tramadol hydrochloride 50 mg - tramadol hydrochloride tablets are indicated for the management of moderate to moderately severe pain in adults. tramadol hydrochloride should not be administered to patients who have previously demonstrated hypersensitivity to tramadol, any other component of this product or opioids. tramadol hydrochloride is contraindicated in any situation where opioids are contraindicated, including acute intoxication with any of the following: alcohol, hypnotics, narcotics, centrally acting analgesics, opioids or psychotropic drugs. tramadol hydrochloride may worsen central nervous system and respiratory depression in these patients. tramadol has mu-opioid agonist activity. tramadol hydrochloride can be abused and may be subject to criminal diversion. addiction is a primary, chronic, neurobiologic disease, with genetic, psychosocial, and environmental factors influencing its development and manifestations. drug addiction is characterized by behaviors that include one or more of the following: impaired control over drug u

TRAMADOL HYDROCHLORIDE tablet United States - English - NLM (National Library of Medicine)

tramadol hydrochloride tablet

dispensing solutions, inc. - tramadol hydrochloride (unii: 9n7r477wck) (tramadol - unii:39j1lgj30j) - tramadol hydrochloride 50 mg - tramadol hydrochloride tablets, usp are indicated for the management of moderate to moderately severe pain in adults. tramadol hydrochloride tablets should not be administered to patients who have previously demonstrated hypersensitivity to tramadol, any other component of this product or opioids. tramadol hydrochloride is contraindicated in any situation where opioids are contraindicated, including acute intoxication with any of the following: alcohol, hypnotics, narcotics, centrally acting analgesics, opioids or psychotropic drugs. tramadol may worsen central nervous system and respiratory depression in these patients. tramadol has mu-opioid agonist activity. tramadol hydrochloride tablet can be abused and may be subject to criminal diversion. addiction is a primary, chronic, neurobiologic disease, with genetic, psychosocial, and environmental factors influencing its development and manifestations. drug addiction is characterized by behaviors that include one or more of the following: impaired control over

TRAMADOL HYDROCHLORIDE- tramadol hydrochloride tablet United States - English - NLM (National Library of Medicine)

tramadol hydrochloride- tramadol hydrochloride tablet

remedyrepack inc. - tramadol hydrochloride (unii: 9n7r477wck) (tramadol - unii:39j1lgj30j) - tramadol hydrochloride 50 mg - tramadol hydrochloride tablets are indicated for the management of moderate to moderately severe pain in adults. tramadol hydrochloride should not be administered to patients who have previously demonstrated hypersensitivity to tramadol, any other component of this product or opioids. tramadol hydrochloride is contraindicated in any situation where opioids are contraindicated, including acute intoxication with any of the following: alcohol, hypnotics, narcotics, centrally acting analgesics, opioids or psychotropic drugs. tramadol hydrochloride may worsen central nervous system and respiratory depression in these patients. tramadol has mu-opioid agonist activity. tramadol hydrochloride can be abused and may be subject to criminal diversion. addiction is a primary, chronic, neurobiologic disease, with genetic, psychosocial, and environmental factors influencing its development and manifestations. drug addiction is characterized by behaviors that include one or more of the following: impaired control over drug u

TRAMADOL HYDROCHLORIDE- tramadol hydrochloride capsule, extended release United States - English - NLM (National Library of Medicine)

tramadol hydrochloride- tramadol hydrochloride capsule, extended release

proficient rx lp - tramadol hydrochloride (unii: 9n7r477wck) (tramadol - unii:39j1lgj30j) - tramadol hydrochloride 150 mg - tramadol hydrochloride extended-release is indicated for the management of moderate to moderately severe chronic pain in adults who require around-the-clock treatment of their pain for an extended period of time. tramadol hydrochloride extended-release is contraindicated in patients who have previously demonstrated hypersensitivity to tramadol, any other component of tramadol hydrochloride extended-release, or opioids. reactions range from pruritis to fatal anaphylactoid reactions [see warnings and precautions (5.4)]. tramadol hydrochloride extended-release is contraindicated in patients with significant respiratory depression in unmonitored settings or the absence of resuscitative equipment. tramadol hydrochloride extended-release is contraindicated in patients with acute or severe bronchial asthma or hypercapnia in unmonitored settings or the absence of resuscitative equipment. teratogenic effects: pregnancy category c there are no adequate and well-controlled studies in pregnant women. use tramadol hydroch

TRAMADOL HYDROCHLORIDE capsule, extended release United States - English - NLM (National Library of Medicine)

tramadol hydrochloride capsule, extended release

medsource pharmaceuticals - tramadol hydrochloride (unii: 9n7r477wck) (tramadol - unii:39j1lgj30j) - tramadol hydrochloride 150 mg - tramadol hydrochloride extended-release is indicated for the management of moderate to moderately severe chronic pain in adults who require around-the-clock treatment of their pain for an extended period of time. tramadol hydrochloride extended-release is contraindicated in patients who have previously demonstrated hypersensitivity to tramadol, any other component of tramadol hydrochloride extended-release, or opioids. reactions range from pruritis to fatal anaphylactoid reactions [see warnings and precautions ( 5.4)]. tramadol hydrochloride extended-release is contraindicated in patients with significant respiratory depression in unmonitored settings or the absence of resuscitative equipment. tramadol hydrochloride extended-release is contraindicated in patients with acute or severe bronchial asthma or hypercapnia in unmonitored settings or the absence of resuscitative equipment. teratogenic effects: pregnancy category c there are no adequate and well-controlled studies in pregna

TRAMADOL HYDROCHLORIDE capsule, extended release United States - English - NLM (National Library of Medicine)

tramadol hydrochloride capsule, extended release

h.j. harkins company, inc. - tramadol hydrochloride (unii: 9n7r477wck) (tramadol - unii:39j1lgj30j) - tramadol hydrochloride 150 mg - tramadol hydrochloride extended-release is indicated for the management of moderate to moderately severe chronic pain in adults who require around-the-clock treatment of their pain for an extended period of time. tramadol hydrochloride extended-release is contraindicated in patients who have previously demonstrated hypersensitivity to tramadol, any other component of tramadol hydrochloride extended-release, or opioids. reactions range from pruritis to fatal anaphylactoid reactions [see warnings and precautions (5.4)]. tramadol hydrochloride extended-release is contraindicated in patients with significant respiratory depression in unmonitored settings or the absence of resuscitative equipment. tramadol hydrochloride extended-release is contraindicated in patients with acute or severe bronchial asthma or hypercapnia in unmonitored settings or the absence of resuscitative equipment. teratogenic effects: pregnancy category c there are no adequate and well-controlled studies in pregnant women. use tramadol hydroc

TRAMADOL HYDROCHLORIDE capsule, extended release United States - English - NLM (National Library of Medicine)

tramadol hydrochloride capsule, extended release

nucare pharmaceuticals, inc. - tramadol hydrochloride (unii: 9n7r477wck) (tramadol - unii:39j1lgj30j) - tramadol hydrochloride 150 mg - tramadol hydrochloride extended-release is indicated for the management of moderate to moderately severe chronic pain in adults who require around-the-clock treatment of their pain for an extended period of time. tramadol hydrochloride extended-release is contraindicated in patients who have previously demonstrated hypersensitivity to tramadol, any other component of tramadol hydrochloride extended-release, or opioids. reactions range from pruritis to fatal anaphylactoid reactions [see warnings and precautions ( 5.4 )]. tramadol hydrochloride extended-release is contraindicated in patients with significant respiratory depression in unmonitored settings or the absence of resuscitative equipment. tramadol hydrochloride extended-release is contraindicated in patients with acute or severe bronchial asthma or hypercapnia in unmonitored settings or the absence of resuscitative equipment. teratogenic effects: pregnancy category c there are no adequate and well-controlled studies in pregnant women.